Cocrystal Pharma, Inc. Announces Digital Corporate Communication Channels
BOTHELL, WA -- (Marketwired) -- 05/22/14 -- Cocrystal Pharma, Inc. (the "Company") (OTCBB: COCP)(OTCQB: COCP), a biotechnology company developing new antiviral therapeutics for human diseases, announced today its suite of online corporate communication channels to maintain on-going direct communication with stakeholders. The Company has launched official portals on social media channels including Facebook, Twitter, LinkedIn, Google+ and The Chairman's Blog.
The Chairman's Blog is an online communication portal where Cocrystal Pharma's founders and executives can address topics related to the development of antiviral therapeutics for human diseases as well as specific points of discussion as they relate to key events at Cocrystal Pharma. CEO Gary Wilcox's inaugural blog post is "Picture an Immune System Directed by Human Intelligence." The blog post can be found online at the official Cocrystal Pharma Chairman's Blog profile provided below.
Links to the new communication tools are here:
The Chairman's Blog Profile: http://www.thechairmansblog.com/cocrystal-pharma
About Cocrystal Pharma, Inc.
We are a biopharma company that seeks to develop novel technologies and approaches to create first-in-class and best-in-class broad-spectrum antiviral therapeutics for the treatment and prophylaxis of viral diseases in humans.
TheChairmansBlog.com is an exclusive, online media publication where publicly and privatively held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com
Source: Cocrystal Pharma, Inc.
Released May 22, 2014